References
- Pavani Chalasani, M., MPH Professor of Medicine, Director, Division of Hematology and Oncology, Leader, Breast Cancer Clinical Research Team, Co-Program Leader, Clinical and Translational Oncology Program, George Washington Cancer Center, George Washington University School of Medicine and Health Sciences. Breast Cancer. 2023 Oct 09, 2023 ]; Available from: https://emedicine.medscape.com/article/1947145-overview.
- Alexandre Lafourcade, M.H., Laura Baglietto, Marie-Christine Boutron-Ruault, Laure Dossus, Virginie Rondeau, Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohort. BMC Cancer, 2018; 18: 171.
- Donald Courtney, M.G.D., Brian M. Moloney, Michael K. Barry, Karl Sweeney, Ray P. McLaughlin, Carmel M. Malone, Aoife J. Lowery, and Michael J. Kerin, Breast cancer recurrence: factors impacting occurrence and survival. Ir J Med Sci., 2022; 191(6): 2501–2510.
- Naveen Donthu, S.K., Debmalya Mukherjee, Nitesh Pandey, Weng Marc Lim, How to conduct a bibliometric analysis: An overview and guidelines. Journal of Business Research, 2021. Volume 133.
- Ramon Handerson Gomes Teles, H.F.M., Márcia Regina Cominetti, Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis. International Journal of Nanomedicine, 2023: p. 2321–2336.
- Hassan Abuhassna, F.A., Kawthar Bayoumi, Diaya Uddeen Alzitawi, Ahmed H Alsharif, Noraffandy Yahaya, Understanding Online Learning Readiness among University Students: A Bibliometric Analysis. iJIM, 2022. 16.
- Cao, L., Towe, C.W., Shenk, R., Stabellini, N., Amin, A.L., Montero, A.J., A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis(Article). Cancer, 2022. 128(13): p. 2433–2440.
- Mao, Y., Xiong, Z., Wu, S., Huang, Z., Zhang, R., He, Y., Peng, Y., Ye, Y., Dong, T., Mai, H., The Predictive Value of Magnetic Resonance Imaging-based Texture Analysis in Evaluating Histopathological Grades of Breast Phyllodes Tumor(Article). Journal of Breast Cancer, 2022. 25(2): p. 117–130.
- Rikke Nørgaard Pedersen, B.Ö.E., Lene Mellemkjær, Peer Christiansen, Bent Ejlertsen, Timothy Lee Lash, Mette Nørgaard, Deirdre Cronin-Fenton, The Incidence of Breast Cancer Recurrence 10–32 Years After Primary Diagnosis Journal of the National Cancer Institute, 2022. 114(3).
- Leone, J.P., Cole, B.F., Regan, M.M., Thürlimann, B., Coates, A.S., Rabaglio, M., Giobbie-Hurder, A., Gelber, R.D., Ejlertsen, B., Harvey, V.J., Neven, P., Láng, I., Bonnefoi, H., Wardley, A., Goldhirsch, A., Di Leo, A., Colleoni, M., Vaz-Luis, I., Lin, N.U., Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1–98 clinical trial. Cancer, 2021. 127(5).
- Bahaddin, M.M., A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study. Annals of Medicine and Surgery, 2020. 60.